Bisphosphonates Related Ocular Side Effects: A Case Series and Review of Literature.
Ocul Immunol Inflamm
; 30(7-8): 1995-1999, 2022.
Article
en En
| MEDLINE
| ID: mdl-34014797
ABSTRACT
OBJECTIVE:
To describe the clinical features of patients with bisphosphonate related ocular side effects (BROSE).METHODS:
The medical records of all patients with BROSE between January 2009 and December 2019 were reviewed.RESULTS:
Nine cases with BROSE were identified. All subjects were female. Median age at diagnosis was of 69 years. The leading indication for bisphosphonate treatment was osteoporosis (n=7), Paget's disease of bone (n=1) and breast cancer (n=1). Six (66.67%) patients presented with uveitis, one (11%) episcleritis and two (22%) with orbital inflammation. Five events (55.5%) occurred within 10 days of initiating the bisphosphonate and the rest (44.44%) developed within 2 weeks to 3 years later. Four (44.44%) patients had concurrent thyroid disease. An association was found between underlying thyroid disease or autoimmunity.CONCLUSION:
BROSE is an uncommon complication of bisphosphonate therapy occurring more frequently in patients with an autoimmune predisposition.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Difosfonatos
/
Oftalmopatías
Límite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Año:
2022
Tipo del documento:
Article